The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia
β Scribed by Yupo Ma; Adnan Mansour; B. Nebiyou Bekele; Xian Zhou; Michael J. Keating; Susan O'Brien; Francis J. Giles; Maher Albitar
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 253 KB
- Volume
- 100
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
BACKGROUND
Patients with chronic lymphocytic leukemia (CLL) that transforms to Richter syndrome (RS) frequently show atypical lymphocytes in bone marrow; however, a diagnosis of RS requires confirmation of the presence of sheets of large cells in bone marrow or lymph nodes.
METHODS
In this study, the authors evaluated the clinical significance of scattered large cells in bone marrow. They assessed the possibility of predicting transformation to RS in bone marrow smears by counting the percentages of prolymphocytes and large cells in 78 patients with CLL and 29 patients with lymph node biopsyβconfirmed RS.
RESULTS
The percentage of large cells was found to be correlated with decreasing survival in a continuous fashion (P = 0.006). It is interesting to note that patients who had > 7% large cells in the bone marrow and elevated Ξ²~2~βmicroglobulin (Ξ²~2~βM) levels (> 5 mg/L) had a survival duration identical to that of patients with RS, and these factors together were a strong predictor of RS (P < 0.001).
CONCLUSIONS
Patients with CLL who had bone marrow that contained > 7% large cells and who had Ξ²~2~βM levels > 5 mg/L had a disease that was similar to RS, and the combination of large cells and Ξ²~2~βM can be used as a surrogate marker for RS. Cancer 2004. Β© 2004 American Cancer Society.
π SIMILAR VOLUMES
Although bone marrow biopsy pattern (BMBP) has long been suggested to be an independent prognostic factor in chronic lymphocytic leukemia (CLL), conflicting reports continue to appear in the literature. To investigate this issue we retrospectively reviewed 70 CLL patients who had undergone bone marr
## BACKGROUND. Although patients with chronic lymphocytic leukemia (CLL) have an increased risk of developing second primary malignancies, including lung carcinoma, there is virtually no information about their clinical outcomes. To evaluate this, the authors reviewed their 20-year institutional e
## Abstract ## BACKGROUND The ubiquitinβproteasome pathway has been implicated in the pathogenesis of many hematologic malignancies. ## METHODS The authors measured proteasome peptidase activity levels in plasma samples from 225 patients with chronic lymphocytic leukemia (CLL) and correlated the